C-Locked Analogs of the Antimicrobial Peptide BP214.

Andersen, Ida Kristine Lysgaard et al.·Antibiotics (Basel·2022·
RPEP-059862022RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Analog 13 showed MIC = 4 µg/mL against E. coli and 36% hemolysis at 150 µM.

Key Numbers

How They Did This

The study involved synthesizing peptide analogs and testing their antimicrobial activity against various bacteria.

Why This Research Matters

The findings could lead to new treatments for infections caused by antibiotic-resistant bacteria, which are a growing public health concern.

What This Study Doesn't Tell Us

The study primarily focused on in vitro testing, which may not fully predict effectiveness in humans.

Trust & Context

Original Title:
C-Locked Analogs of the Antimicrobial Peptide BP214.
Published In:
Antibiotics (Basel, Switzerland), 11(8) (2022)
Database ID:
RPEP-05986

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-05986·https://rethinkpeptides.com/research/RPEP-05986

APA

Andersen, Ida Kristine Lysgaard; Thomsen, Thomas T; Rashid, Jasmina; Bobak, Thomas Rønnemoes; Oddo, Alberto; Franzyk, Henrik; Løbner-Olesen, Anders; Hansen, Paul R. (2022). C-Locked Analogs of the Antimicrobial Peptide BP214.. Antibiotics (Basel, Switzerland), 11(8). https://doi.org/10.3390/antibiotics11081080

MLA

Andersen, Ida Kristine Lysgaard, et al. "C-Locked Analogs of the Antimicrobial Peptide BP214.." Antibiotics (Basel, 2022. https://doi.org/10.3390/antibiotics11081080

RethinkPeptides

RethinkPeptides Research Database. "C-Locked Analogs of the Antimicrobial Peptide BP214." RPEP-05986. Retrieved from https://rethinkpeptides.com/research/andersen-2022-clocked-analogs-of-the

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.